换一批
换一批
作者：
Jeremy M,Levin [1]
;
Steven H,Holtzman [2]
;
John,Maraganore [3]
;
Paul J,Hastings [4]
;
Ron,Cohen [5]
;
Bassil,Dahiyat [6]
;
Julian,Adams [7]
;
Chris,Adams [8]
;
Brett,Ahrens [9]
;
Jeff,Albers [10]
;
Mara G,Aspinall [11]
;
James E,Audia [12]
;
Martin,Babler [13]
;
Peter,Barrett [14]
;
Zoe,Barry [15]
;
Nessan,Bermingham [16]
;
Stephen,Bloch [17]
;
Robert I,Blum [18]
;
Paul B,Bolno [19]
;
Michael W,Bonney [3]
;
Bruce,Booth [14]
;
Daniel M,Bradbury [20]
;
Steven K,Brauer [21]
;
Brook,Byers [22]
;
Pablo J,Cagnoni [23]
;
Brian M,Cali [24]
;
Isaac,Ciechanover [25]
;
Chip,Clark [26]
;
Michael D,Clayman [27]
;
Jeff L,Cleland [28]
;
Paula,Cobb [2]
;
Ron,Cooper [29]
;
Mark G,Currie [24]
;
John,Diekman [30]
;
Eric L,Dobmeier [31]
;
Doug,Doerfler [32]
;
Elizabeth Lr,Donley [33]
;
Deborah,Dunsire [34]
;
Matthew,During [1]
;
Jens W,Eckstein [35]
;
Eric,Elenko [36]
;
Neil A,Exter [37]
;
Jonathan J,Fleming [38]
;
Gregory J,Flesher [39]
;
Jean-Francois,Formela [14]
;
Robert,Forrester [40]
;
Cedric,Francois [41]
;
Heather,Franklin [42]
;
Mason W,Freeman [30]
;
Howard,Furst [43]
;
Leonard Patrick,Gage [44]
;
Nicholas,Galakatos [45]
;
Brian M,Gallagher [46]
;
James A,Geraghty [47]
;
Simba,Gill [48]
;
David V,Goeddel [49]
;
Mark A,Goldsmith [50]
;
Maxine,Gowen [51]
;
Vikas,Goyal [46]
;
Tom,Graney [24]
;
David,Grayzel [14]
;
Barry,Greene [3]
;
Paul,Grint [52]
;
J C,Gutierrez-Ramos [53]
;
Bill,Haney [54]
;
Tuan,Ha-Ngoc [55]
;
Tim,Harris [56]
;
Faheem,Hasnain [57]
;
Yujiro Steve,Hata [58]
;
Peter,Hecht [24]
;
Leslie,Henshaw [43]
;
Rich,Heyman [59]
;
Herve,Hoppenot [60]
;
H Robert,Horvitz [61]
;
Thomas E,Hughes [62]
;
Wende S,Hutton [9]
;
Stephen T,Isaacs [63]
;
Annalisa,Jenkins [64]
;
Jeff,Jonker [65]
;
Jeff,Kaplan [43]
;
Perry,Karsen [16]
;
Jeb,Keiper [66]
;
Jean,Kim [43]
;
Jeff,Kindler [67]
;
Rachel,King [68]
;
Vanessa,King [69]
;
Nina,Kjellson [9]
;
Scott,Koenig [70]
;
Gerhard,Koenig [71]
;
Peter,Kolchinsky [72]
;
Paul,Laikind [73]
;
Robert Bob,Langer [61]
;
John J,Lee [2]
;
Jonathan S,Leff [43]
;
Bruce A,Leicher [74]
;
Nick,Leschly [75]
;
Andrew,Levin [72]
;
Mark,Levin [37]
;
Arnold J,Levine [76]
;
Alan,Levy [77]
;
David R,Liu [78]
;
Harvey F,Lodish [79]
;
Uri,Lopatin [80]
;
Ted W,Love [81]
;
Guy,Macdonald [44]
;
Gail J,Maderis [82]
;
Ankit,Mahadevia [83]
;
Nagesh K,Mahanthappa [84]
;
Joel F,Martin [85]
;
Alex,Martin [86]
;
W Eddie,Martucci [87]
;
James G,McArthur [88]
;
Corey M,McCann [89]
;
Sean A,McCarthy [90]
;
C Geoffrey,McDonough [91]
;
John,Mendlein [92]
;
Larry,Miller [93]
;
Diego,Miralles [94]
;
Kenneth I,Moch [95]
;
Bob,More [96]
;
Andrew G,Myers [97]
;
Michael A,Narachi [98]
;
Amir,Nashat [99]
;
Wendy,Nelson [100]
;
William J,Newell [101]
;
Bernat,Olle [102]
;
John E,Osborn [103]
;
Julia C,Owens [104]
;
Atul,Pande [105]
;
Stelios,Papadopoulos [106]
;
H Stewart,Parker [107]
;
Kush M,Parmar [30]
;
Matthew R,Patterson [108]
;
Steve M,Paul [109]
;
Rob,Perez [110]
;
Matthew,Perry [111]
;
Cary G,Pfeffer [37]
;
Mike,Powell [112]
;
Mark,Pruzanski [113]
;
Dennis J,Purcell [114]
;
Amit,Rakhit [1]
;
Kartik,Ramamoorthi [115]
;
William,Rastetter [116]
;
Adrian Ad,Rawcliffe [117]
;
Laurence E,Reid [118]
;
Ron C,Renaud [119]
;
Jason P,Rhodes [14]
;
William J,Rieflin [65]
;
Chad,Robins [94]
;
Scott M,Rocklage [120]
;
Michael,Rosenblatt [121]
;
Jonathan G,Rosin [24]
;
William J,Rutter [122]
;
Saurabh,Saha [123]
;
Camille,Samuels [124]
;
Vicki L,Sato [125]
;
George,Scangos [126]
;
John A,Scarlett [127]
;
David,Schenkein [128]
;
Stuart L,Schreiber [129]
;
Andrew,Schwab [120]
;
Paul,Sekhri [130]
;
Rajeev,Shah [72]
;
Thomas,Shenk [131]
;
Clay B,Siegall [31]
;
Nick J,Simon [132]
;
Nancy,Simonian [133]
;
Jeff,Stein [134]
;
Michael,Su [2]
;
Mary T,Szela [135]
;
Marco,Taglietti [136]
;
Nina,Tandon [137]
;
Henri,Termeer [138]
;
Nancy A,Thornberry [139]
;
Martin,Tolar [140]
;
Richard,Ulevitch [141]
;
Akshay K,Vaishnaw [3]
;
Anne,VanLent [142]
;
Martin,Varsavsky [143]
;
George P,Vlasuk [144]
;
Michel,Vounatsos [145]
;
Samuel G,Waksal [146]
;
Neil,Warma [147]
;
Ryan J,Watts [148]
;
Yaron,Werber [1]
;
Christoph,Westphal [149]
;
Wendell,Wierenga [150]
;
Doug E,Williams [151]
;
Lewis Rusty,Williams [152]
;
Kleanthis G,Xanthopoulos [153]
;
Daphne,Zohar [36]
;
Sandford Sandy,Zweifach [154]
作者单位：
Ovid Therapeutics, New York, New York, USA.
[1]
Decibel Therapeutics, Cambridge, Massachusetts, USA.
[2]
Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA.
[3]
OncoMed Pharmaceuticals, Redwood City, California, USA.
[4]
Acorda Therapeutics, Inc., Ardsley, New York, USA.
[5]
Xencor, Monrovia, California, USA.
[6]
Clal Biotechnology Industries (CBI), Cambridge, Massachusetts, USA.
[7]
Cydan Development Inc., Cambridge, Massachusetts, USA.
[8]
Canaan Partners, Menlo Park, California, USA.
[9]
Blueprint Medicines, Cambridge, Massachusetts, USA.
[10]
Health Catalysts, Tucson, Arizona, USA.
[11]
Constellation Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.
[12]
Principia Biopharma, South San Francisco, California, USA.
[13]
Atlas Venture, Cambridge, Massachusetts, USA.
[14]
ZappRx, Boston, Massachusetts, USA.
[15]
Intellia Therapeutics, Cambridge, Massachusetts, USA.
[16]
Canaan Partners, Westport, Connecticut, USA.
[17]
Cytokinetics, Inc., South San Francisco, California, USA.
[18]
Wave Life Sciences, Cambridge, Massachusetts, USA.
[19]
Amylin Pharmaceuticals, San Diego, California, USA.
[20]
Salus Discovery LLC, San Diego, California, USA.
[21]
Biotech Venture Capitalist since 1978, Menlo Park, California, USA.
[22]
Tizona Therapeutics, Inc., South San Francisco, California, USA.
[23]
Ironwood Pharmaceuticals, Cambridge, Massachusetts, USA.
[24]
Atara Bio, South San Francisco, California, USA.
[25]
Genocea Biosciences, Inc., Cambridge, Massachusetts, USA.
[26]
Flexion Therapeutics, Burlington, Massachusetts, USA.
[27]
Graybug Vision, Redwood City, California, USA.
[28]
Albireo Pharma Inc., Boston, Massachusetts, USA.
[29]
5AM Ventures, Boston, Massachusetts, USA.
[30]
Seattle Genetics, Bothell, Washington, USA.
[31]
MaxCyte, Inc., Gaithersburg, Maryland, USA.
[32]
NeuroPoint Dx, Madison, Wisconsin, USA.
[33]
Southern Cross Biotech Consulting, Waltham, Massachusetts, USA.
[34]
SR One, Conshohocken, Pennsylvania, USA.
[35]
PureTech Health, Boston, Massachusetts, USA.
[36]
Third Rock Ventures, Boston, Massachusetts, USA.
[37]
Q-State Biosciences, Cambridge, Massachusetts, USA.
[38]
OticPharma Inc., Irvine, California, USA.
[39]
Verastem Inc., Needham, Massachusetts, USA.
[40]
Apellis Pharmaceuticals, Crestwood, Kentucky, USA.
[41]
Blaze Bioscience Inc., Seattle, Washington, USA.
[42]
Deerfield Management, New York, New York, USA.
[43]
Tetraphase, Watertown, Massachusetts, USA.
[44]
Clarus, Cambridge, Massachusetts, USA.
[45]
SR One, Ltd., Cambridge, Massachusetts, USA.
[46]
Juniper Pharmaceuticals, Boston, Massachusetts, USA.
[47]
Evelo Biosciences, Cambridge, Massachusetts, USA.
[48]
The Column Group, San Francisco, California, USA.
[49]
Revolution Medicines, Inc., Redwood City, California, USA.
[50]
Trevena Inc., King of Prussia, Pennsylvania, USA.
[51]
Regulus Therapeutics, San Diego, California, USA.
[52]
Synlogic, Cambridge, Massachusetts, USA.
[53]
Dragonfly Therapeutics, Inc., Cambridge, Massachusetts, USA.
[54]
KEW, Inc., Cambridge, Massachusetts, USA.
[55]
SV Life Sciences, Boston, Massachusetts, USA.
[56]
FSG Biotech, San Diego, California, USA.
[57]
IDEAYA Biosciences, South San Francisco, California, USA.
[58]
Metacrine, Inc., San Diego, California, USA.
[59]
Incyte, Wilmington, Delaware, USA.
[60]
Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
[61]
Zafgen, Inc., Boston, Massachusetts, USA.
[62]
Aduro Biotech, Berkley, California, USA.
[63]
Dimension Therapeutics, Cambridge, Massachusetts, USA.
[64]
NGM Biopharmaceuticals, Inc., South San Francisco, California, USA.
[65]
Nimbus Therapeutics, Cambridge, Massachusetts, USA.
[66]
Centrexion Therapeutics Inc., Boston, Massachusetts, USA.
[67]
GlycoMimetics, Inc., Rockville, Maryland, USA.
[68]
Luc Therapeutics, Inc., Cambridge, Massachusetts, USA.
[69]
MacroGenics, Inc., Rockville, Maryland, USA.
[70]
Quartet Medicine, Cambridge, Massachusetts, USA.
[71]
RA Capital Management, LLC, Boston, Massachusetts, USA.
[72]
ViaCyte, Inc., San Diego, California, USA.
[73]
Momenta Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.
[74]
Bluebird Bio, Cambridge, Massachusetts, USA.
[75]
Institute for Advanced Study, Princeton, New Jersey, USA.
[76]
Chrono Therapeutics, Hayward, California, USA.
[77]
Editas Medicine, Cambridge, Massachusetts, USA.
[78]
Whitehead Institute MIT, Cambridge, Massachusetts, USA.
[79]
Assembly Biosciences, Carmel, Indiana, USA.
[80]
Global Blood Therapeutics, South San Francisco, California, USA.
[81]
Antiva Biosciences, Inc., South San Francisco, California, USA.
[82]
Spero Therapeutics, Cambridge, Massachusetts, USA.
[83]
Scholar Rock, Cambridge, Massachusetts, USA.
[84]
Dauntless Pharmaceuticals, Inc., San Diego, California, USA.
[85]
Realm Therapeutics, Malvern, Pennsylvania, USA.
[86]
Akili Interactive, Boston, Massachusetts, USA.
[87]
Imara, Cambridge, Massachusetts, USA.
[88]
Pear Therapeutics, Boston, Massachusetts, USA.
[89]
CytomX, South San Francisco, California, USA.
[90]
Sobi, Waltham, Massachusetts, USA.
[91]
aTyr Pharma, San Diego, California, USA.
[92]
Macrolide Pharmaceuticals, Watertown, Massachusetts, USA.
[93]
Adaptive Biotechnologies, Seattle, Washington, USA.
[94]
Cognition Therapeutics, Inc., Pittsburgh, Pennsylvania, USA.
[95]
Alta Partners, San Francisco, California, USA.
[96]
Harvard University, Cambridge, Massachusetts, USA.
[97]
Orexigen Therapeutics, La Jolla, California, USA.
[98]
Polaris Partners, Boston, Massachusetts, USA.
[99]
Boston Biotech Forum, Cambridge, Massachusetts, USA.
[100]
Sutro Biopharma, Inc., South San Francisco, California, USA.
[101]
Vedanta Biosciences, Inc., Cambridge, Massachusetts, USA.
[102]
Egalet, Wayne, Pennsylvania, USA.
[103]
Millendo Therapeutics, Inc., Ann Arbor, Michigan, USA.
[104]
Verity BioConsulting, San Diego, California, USA.
[105]
Biogen Inc., Exelixis Inc. &Regulus Therapeutics Inc., Great Neck, New York, USA.
[106]
Parker BioConsulting, Seattle, Washington, USA.
[107]
Audentes Therapeutics, Inc., San Francisco, California, USA.
[108]
Voyager Therapeutics, Inc., Cambridge, Massachusetts, USA.
[109]
Life Science Cares, Boston, Massachusetts, USA.
[110]
BVF Partners, LP, San Francisco, California, USA.
[111]
Sofinnova Ventures, Menlo Park, California, USA.
[112]
Intercept Pharma, New York, New York, USA.
[113]
Aisling Capital, New York, New York, USA.
[114]
Encoded Genomics, South San Francisco, California, USA.
[115]
Neurocrine Biosciences Inc., San Diego, California, USA.
[116]
Adaptimmune, Philadelphia, Pennsylvania, USA.
[117]
Warp Drive Bio, Cambridge, Massachusetts, USA.
[118]
RaNa Therapeutics, Cambridge, Massachusetts, USA.
[119]
5AM Ventures, San Francisco, California, USA.
[120]
Flagship Pioneering, Cambridge, Massachusetts, USA.
[121]
Synergenics, LLC, San Francisco, California, USA.
[122]
Delinia, Cambridge, Massachusetts, USA.
[123]
Venrock, Palo Alto, California, USA.
[124]
Harvard Business School, Cambridge, Massachusetts, USA.
[125]
Vir Bio, San Francisco, California, USA.
[126]
Geron Corporation, Menlo Park, California, USA.
[127]
Agios, Cambridge, Massachusetts, USA.
[128]
Broad Institute, Cambridge, Massachusetts, USA.
[129]
Lycera Corporation, New York, New York, USA.
[130]
Lewis Thomas Laboratory, Princeton, New Jersey, USA.
[131]
Clarus Ventures LLC, South San Francisco, California, USA.
[132]
Syros Pharmaceuticals, Cambridge, Massachusetts, USA.
[133]
Cidara Therapeutics, San Diego, California, USA.
[134]
Novelion Therapeutics, Vancouver, British Columbia, USA.
[135]
SCYNEXIS, Inc., Jersey City, New Jersey, USA.
[136]
EpiBone, Inc., New York, New York, USA.
[137]
Genzyme Corporation (former CEO), Cambridge, Massachusetts, USA.
[138]
Kallyope, New York, New York, USA.
[139]
Alzheon, Framingham, Massachusetts, USA.
[140]
5AM Ventures, La Jolla, California, USA.
[141]
AMV Advisors, Princeton, New Jersey, USA.
[142]
Prelude Fertility, Inc., Atlanta, Georgia, USA.
[143]
Navitor Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.
[144]
Biogen, Cambridge, Massachusetts, USA.
[145]
MeiraGTx, New York, New York, USA.
[146]
Opexa Therapeutics, Inc., The Woodlands, Texas, USA.
[147]
Denali Therapeutics Inc., South San Francisco, California, USA.
[148]
Flex Pharma, Boston, Massachusetts, USA.
[149]
Crinetics Pharmaceuticals, San Diego, California, USA.
[150]
Codiak BioSciences, Cambridge, Massachusetts, USA.
[151]
Five Prime Therapeutics, Inc., South San Francisco, California, USA.
[152]
Cerus, La Jolla, California, USA.
[153]
Nuvelution Pharmaceuticals, Inc., South San Francisco, California, USA.
[154]
主题词
生物技术(Biotechnology);移民(移出和移入)(Emigration and Immigration);人类(Humans);人口动力学(Population Dynamics);政府政策(Public Policy)
DOI
10.1038/nbt.3824
PMID
28267733
发布时间
2018-03-09
- 浏览16
Nature biotechnology
Nature biotechnology
204-206页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
